ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 82 filers reported holding ALLOVIR INC in Q4 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $350,682 | -37.2% | 163,108 | -0.6% | 0.00% | – |
| Q2 2023 | $558,188 | +94188.5% | 164,173 | +9.2% | 0.00% | – |
| Q1 2023 | $592 | -28.8% | 150,356 | -7.2% | 0.00% | – |
| Q4 2022 | $831 | -99.9% | 161,976 | -8.3% | 0.00% | -100.0% |
| Q3 2022 | $1,394,000 | +100.9% | 176,629 | -0.8% | 0.00% | – |
| Q2 2022 | $694,000 | +13.2% | 178,060 | +120.3% | 0.00% | – |
| Q1 2022 | $613,000 | -46.6% | 80,814 | +0.7% | 0.00% | – |
| Q4 2021 | $1,149,000 | -44.8% | 80,233 | -7.6% | 0.00% | -100.0% |
| Q3 2021 | $2,082,000 | +18.9% | 86,808 | -2.1% | 0.00% | 0.0% |
| Q2 2021 | $1,751,000 | -25.0% | 88,704 | -11.1% | 0.00% | 0.0% |
| Q1 2021 | $2,334,000 | -23.6% | 99,739 | +25.6% | 0.00% | 0.0% |
| Q4 2020 | $3,053,000 | +47.1% | 79,413 | +5.2% | 0.00% | 0.0% |
| Q3 2020 | $2,076,000 | – | 75,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |